FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Mike Blake | Reuters The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their firstContinue Reading